Volitionrx (VNRX) Operating Expenses (2011 - 2025)

Volitionrx (VNRX) has 11 years of Operating Expenses data on file, last reported at $5.3 million in Q4 2025.

• For the quarter ending Q4 2025, Operating Expenses fell 11.85% year-over-year to $5.3 million; the trailing twelve-month figure through Dec 2025 stood at $23.5 million (down 16.96% YoY), and the FY2025 full-year result was $23.5 million, down 16.96% from the prior year.
• Operating Expenses for Q4 2025 stood at $5.3 million, down from $5.7 million in the prior quarter.
• Across five years, Operating Expenses topped out at $9.8 million in Q2 2023 and bottomed at $5.3 million in Q4 2025.
• The 5-year median for Operating Expenses is $7.7 million (2021), against an average of $7.4 million.
• The widest annual swing landed in 2021, when Operating Expenses soared 68.43%; it then plunged 33.52% in 2024.
• A 5-year view of Operating Expenses shows it stood at $8.8 million in 2021, then decreased by 7.6% to $8.1 million in 2022, then advanced by 10.51% to $9.0 million in 2023, then slumped by 33.52% to $6.0 million in 2024, then retreated by 11.85% to $5.3 million in 2025.
• The last three Operating Expenses figures came in at $5.3 million (Q4 2025), $5.7 million (Q3 2025), and $6.7 million (Q2 2025), per Business Quant data.

Peer Comparison